Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cognition Therapeutics, Inc. - Common Stock (NQ:CGTX)

1.580 +0.360 (+29.51%)
Streaming Delayed Price Updated: 2:14 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,611,867
Open 1.210
Bid (Size) 1.570 (124)
Ask (Size) 1.580 (16)
Prev. Close 1.220
Today's Range 1.145 - 1.810
52wk Range 0.2223 - 1.470
Shares Outstanding 64,962,957
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Thursday's session: top gainers and losers
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill

Performance

YTD
+118.5%
+118.5%
1 Month
+161.2%
+161.2%
3 Month
+373.8%
+373.8%
6 Month
+160.0%
+160.0%
1 Year
+167.8%
+167.8%

More News

Read More
Wednesday's session: gap up and gap down stocks
Via Chartmill
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Cognition Therapeutics Surges 30% Pre-Market After FDA Backs Phase 3 Trial Design For Alzheimer's Drug
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Get insights into the top gainers and losers of Tuesday's after-hours session.
Via Chartmill
Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition (CGTX) Q2 Grant Income Jumps
Via The Motley Fool
Topics Intellectual Property
Cognition Therapeutics Reports Financial Results for the Second Quarter 2025 and Highlights Progress Across Clinical Programs
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Cognition Therapeutics Presents Data at AAIC Highlighting Broad Neurological Impact of Zervimesine (CT1812) in Dementia with Lewy Bodies and Alzheimer’s Disease
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Power Metallic Mines (TSXV: PNPN | OTCQB: PNPNF) Issues Summer 2025 “BIG Picture” Exploration Update – More Stocks Inside
Via AB Newswire
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Curious about the most active stocks on Thursday?
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Which stocks are experiencing notable movement on Thursday?
Via Chartmill
Thursday's session: gap up and gap down stocks
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Monday's after hours session: top gainers and losers
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill

Frequently Asked Questions

Is Cognition Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cognition Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cognition Therapeutics, Inc. - Common Stock trade on?
Cognition Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cognition Therapeutics, Inc. - Common Stock?
The ticker symbol for Cognition Therapeutics, Inc. - Common Stock is CGTX on the Nasdaq Stock Market
What is the current price of Cognition Therapeutics, Inc. - Common Stock?
The current price of Cognition Therapeutics, Inc. - Common Stock is 1.580
When was Cognition Therapeutics, Inc. - Common Stock last traded?
The last trade of Cognition Therapeutics, Inc. - Common Stock was at 08/14/25 02:14 PM ET
What is the market capitalization of Cognition Therapeutics, Inc. - Common Stock?
The market capitalization of Cognition Therapeutics, Inc. - Common Stock is 102.64M
How many shares of Cognition Therapeutics, Inc. - Common Stock are outstanding?
Cognition Therapeutics, Inc. - Common Stock has 103M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.